The Clinical Course of Coronary Artery Disease in Coronary Multidetector Computed Tomographic Angiogram

NCT ID: NCT01142973

Last Updated: 2010-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-09-30

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study Type: Observational Study Design: Observational Model: Defined Population Observational Model: Natural History Time Perspective: Longitudinal Time Perspective: Prospective

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The natural history of individual plaques is unknown and needs to be established. Multidetector computed tomography (MDCT) angiography is a useful noninvasive imaging modality for assessing coronary plaque. Using MDCT, the researchers prospectively investigate the relationship between the presence of coronary plaques and cardiovascular events

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atherosclerosis Cardiovascular Diseases Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with known or suspected coronary artery disease

Exclusion Criteria

* Irregular heart beat
* Known allergy towards the contrast agent
* Renal dysfunction
* Impossible breath-hold
* Acute coronary syndrome patient
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Inje University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Inje university ILSAN paik hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sung Uk Kwon, M.D.

Role: PRINCIPAL_INVESTIGATOR

Inje univ. ilsan paik hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ilsan Paik hospital

Goyang, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sung Uk Kwon, M.D.

Role: CONTACT

82-31-910-7041

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sung Uk Kwon, M.D.

Role: primary

82-31-910-7041

References

Explore related publications, articles, or registry entries linked to this study.

Kim JB, Rogers IS, Kwon SU. Presence of plaques predicts worse outcomes in multi-detector computed tomography in patients with stable chest pain syndrome. Int J Cardiol. 2014 May 15;173(3):570-2. doi: 10.1016/j.ijcard.2014.03.118. Epub 2014 Mar 21. No abstract available.

Reference Type DERIVED
PMID: 24717325 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

mdksu-mdct-001

Identifier Type: -

Identifier Source: org_study_id